| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |